Monday, 19 September 2011

Hetero Launches Dapoxetine Drug for Premature Ejaculation Treatment in India

India, Mumbai, 18th July 2011: Premature Ejaculation (PE), also known as rapid ejaculation or early ejaculation, is a very common sexual problem, affecting 30%-60% of male population. It indicates a lack of control over ejaculation, leading to cessation of intimate activity earlier than normal and/or before wishes of individual partners.
Although PE is not life threatening, it negatively impacts quality of life of man and his partner. Despite the high prevalence of PE, few men actually seek treatment. In an interview conducted, the primary reason cited by men for not consulting a physician about their PE was the embarrassment of talking about this topic (67%). But nearly half the men (47%) also believe that there is no treatment and therefore have never considered consulting a physician.
Hetero, with long track record of developing and marketing novel and advanced drug molecules, has now introduced Dapoxetine under the brand name Kutub for the benefit of Indian patients suffering from PE. The product is available on doctor’s prescription across medical stores all over India
Dapoxetine heralds a new beginning in the treatment of PE. Dapoxetine is a unique medicine (tablet), designed to be taken only when needed, that is 1-3 hours before anticipated sexual intercourse, rather than every day. Dapoxetine has been extensively studied and results documented through various trials worldwide. The initial starting dose of Dapoxetine is 30 mg or may be increased to 60 mg based on efficacy and tolerability once in every 24 hours, 1-3 hours before sexual intercourse.
Hetero Healthcare Ltd., a part of Hetero Drugs, has been at the frontlines of process development for manufacture of latest drug molecules and has recently been the largest supplier of Oseltamivir to the Govt. of India during the H1N1 pandemic.

Availability & Price of Kutub:
• Available on doctor’s prescription at medical stores all over the country
• Price is Rs. 79.00 for 4 tablets pack of Kutub 30 mg and Rs. 149.00 for 4 tablets pack of Kutub 60 mg

About Hetero Healthcare Limited:
Hetero Healthcare Ltd., a part of Hetero Drugs, has been at the frontlines of process development for manufacture of latest drug molecules and has recently been the largest supplier of Oseltamivir to the Govt. of India during the H1N1 pandemic.
With various manufacturing facilities being supported by excellent infrastructure and compliance to the GMP requirements, Hetero Healthcare manufactures and markets its products in over 100 countries in Asia, Middle-east, Eastern Europe, Latin America, United States, Canada and Europe.
Hetero received National Award for Best Efforts in Research and Development from the Department of Scientific and Industrial Research, Ministry of Science and Technology, Government of India, in the year 1996 and Highest Exporter award for the year 1999.
For more information, please visit www.heterodrugs.com